Categories
news

Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s

Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s